CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Address the consequences of the inappropriate applications of comparative effectiveness research when used simply as a cost containment mechanism.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: Increased NIH and biodefense/pandemicfunding. Support math and science education program funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Education EDU
Support funding for Professional Science Masters program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Medical/Disease Research/Clinical Labs MED
Labor/HHS/Ed Appropriations: Increased NIH and biodefense/pandemicfunding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Copyright/Patent/Trademark CPT
Oppose provisions in patent reform legislation (HR 1260/S 515) that would undermine certainty and weaken patent rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Health Issues HCR
Support legislation (H.R. 1548) to provide for the approval of follow-on biologics (FOBs) Address concerns with application of comparative effectiveness research as a blunt cost containment tool and the consequences to biomedical innovation and patient access. Oppose removal of medical device preemption provision from existing statute (HR 1346/S 540). Support language in healthcare reform providing incentives for hospitals to prevent and reduce incidence of healthcare-associated infections (HIAs)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.